Flurpiridaz F-18 Patent Expiration
Flurpiridaz F-18 was first introduced by Ge Healthcare Inc
Flurpiridaz F-18 Patents
Given below is the list of patents protecting Flurpiridaz F-18, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Flyrcado | US9687571 | Stabilization of radiopharmaceutical compositions using ascorbic acid | Nov 01, 2032 | Ge Hlthcare |
| Flyrcado | US8936777 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof | Jun 30, 2031 | Ge Hlthcare |
| Flyrcado | US9603951 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof | May 02, 2031 | Ge Hlthcare |
| Flyrcado | US8226929 | Contrast agents for myocardial perfusion imaging | Jun 21, 2028 | Ge Hlthcare |
| Flyrcado | US7344702 | Contrast agents for myocardial perfusion imaging | May 26, 2026 | Ge Hlthcare |
| Flyrcado | US9161997 | Contrast agents for myocardial perfusion imaging | Feb 04, 2026 | Ge Hlthcare |
Flurpiridaz F-18's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List